Research Insights

Improvement of voicing in patients with Parkinson’s disease by speech therapy

Neurology

de Swart, Bert J. M; Willemse, S. C; Maassen, B. A. M; Horstink, M. W. I. M. (2003) Improvement of voicing in patients with Parkinson’s disease by speech therapy Neurology, 60(3), 498-500.

Speech therapy in Parkinson’s disease (PD) patients focusing on an increase of phonatory-respiratory effort (the sound made by the combination of breathing and the vibration of the vocal cords) has adverse effects because it raises vocal pitch and laryngeal muscle tension. The authors’ approach, the Pitch Limiting Voice Treatment (PLVT), increases loudness but at the same time sets vocal pitch at a better level. In this study, the Lee Silverman Voice Treatment (think loud, think shout) and PLVT (speak loud and low) are compared. Both treatments produce the same increase in loudness, but PLVT limits an increase in vocal pitch and prevents a strained or pressed voicing.

Click here to read the abstract.

Back

Follow Us Follow us on TwitterFollow us on FacebookInstagram

Sign Up for Email Alerts

By providing your email you agree to receive periodic emails from The Parkinson Alliance.

Please tell us more about yourself:

This month is? (Anti-Spam)

Contact UsTerms Of UsePrivacy Policy

The Parkinson Alliance is a nonprofit, tax-exempt charitable organization under section 501(c)(3) of the Internal Revenue Code. Donations are tax-deductible as allowed by law. Copyright © 2018 The Parkinson Alliance. All rights reserved.